Article Figures & Data
Figures
- 1
CT scans of metastatic cancer with unknown primary site. (A) Large volume of intra-abdominal ascites with a large hypodense mass in the right abdomen measuring approximately 24.1 × 16.3 × 7.9 cm. (B) A 3.6 × 2.4 cm mass-like density in anterior aspect of gastric antrum. (C) A 2.6 × 1.5 cm mass on the lateral aspect of the descending colon. (D) Two masses, including a 4.4 × 2.3 cm eccentric mass along the sigmoid colon without complete obstruction. (E) A superior diaphragmatic lymphadenopathy around 1.8 × 1.1 cm. (F) Peripancreatic adenopathy measuring up to 1.9 × 1.8 cm.
- 2
CT scans and mammogram of worsening metastatic disease since the prior study. (A) A poorly defined hypodense mass, 4.1 × 3.3 cm, in the left lobe of the liver suspicious for metastasis. (B) Two right axillary enlarged lymph nodes, measuring around 2 × 1 × 1 cm. (C) Mammogram showed a 0.8 × 0.7 × 0.8 cm nodule in the right breast on craniocaudal (CC) view.
- 3
Immunochemical and histological appearance of primary peritoneal cancer metastasized to breast. (A) Right breast lumpectomy showed metastatic breast cancer from unknown primary (H&E, 200×). (B) Metastasis was also found in right axillary node (H&E, 200×). (C) WT1 was highly expressed in metastatic breast cancer (IHC, 40×). (D) PAX8 was also highly expressed in metastatic breast cancer (IHC, 40×). (E) No expression of mammoglobin in metastatic breast cancer (IHC, 40×). (F) No expression of GATA3 in metastatic breast cancer (IHC, 40×).
- 4
Molecular markers to distinguish undifferentiated carcinoma.
